Chenyou Du

6PUBLICATIONS
29CO-AUTHORS
Socio-economic developmentCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesLitigation, adjudication and dispute resolutionPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 11, 2025
Global trends and future predictions of pancreatic cancer incidence and mortality from 1990 to 2030: A comparative analysis of China, Korea, Japan, and the USA.

Kun Huang, Xiang Lan, Zhu Chen

|Sep 15, 2025
The combination of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS), interventional hepatoma therapy, targeted therapy, and immunotherapy: a case series of a novel AITI conversion therapy model.

Zhu Chen, Xingyu Chen, Haiyang Hu

|Mar 21, 2025
The combination of extra-Glissonian pedicle ligation of the tumor-bearing area and traditional ALPPS: a novel modified ALPPS method.

Zhu Chen, Xingyu Chen, Haiyang Hu

|Apr 30, 2024
Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial.

Yajin Chen, Chengyou Du, Shunli Shen

|Sep 10, 2020
Increased Surgical Complications but Improved Overall Survival with Adult Living Donor Compared to Deceased Donor Liver Transplantation: A Systematic Review and Meta-Analysis.

Wei Tang, Jian-Guo Qiu, Yang Cai

|Oct 18, 2018
HBV-DNA Load-Related Peritumoral Inflammation and ALBI Scores Predict HBV Associated Hepatocellular Carcinoma Prognosis after Curative Resection.

Rui Liao, Cheng-You Du, Jian-Ping Gong

Pageof 1

Frequent Collaborators

3 joint publications

Heng Xiao

2 joint publications

Xiang Lan

2 joint publications

Haiyang Hu

2 joint publications

Jianguo Qiu